Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0381120130350020141
Genes and Genomics
2013 Volume.35 No. 2 p.141 ~ p.147
Novel mutations of CDKN1C in Japanese patients with Beckwith-Wiedemann syndrome
Yatsuki Hitomi

Higashimoto Ken
Jozaki Kosuke
Koide Kayoko
Okada Junichiro
Watanabe Yoriko
Okamoto Nobuhiko
Tsuno Yoshinobu
Yoshida Yoko
Ueda Kazutoshi
Shimizu Kenji
Ohashi Hirofumi
Mukai Tsunehiro
Soejima Hidenobu
Abstract
Beckwith-Wiedemann syndrome (BWS) is an imprinting-related human disease that is characterized by macrosomia, macroglossia, abdominal wall defects, and variable minor features. BWS is caused by several genetic/epigenetic alterations, such as loss of methylation at KvDMR1, gain of methylation at H19-DMR, paternal uniparental disomy of chromosome 11, CDKN1C mutations, and structural abnormalities of chromosome 11. CDKN1C is an imprinted gene with maternal preferential expression, encoding for a cyclin-dependent kinase (CDK) inhibitor. Mutations in CDKN1C are found in 40 % of familial BWS cases with dominant maternal transmission and in ~5 % of sporadic cases. In this study, we searched for CDKN1C mutations in 37 BWS cases that had no evidence for other alterations. We found five mutations?four novel and one known?from a total of six patients. Four were maternally inherited and one was a de novo mutation. Two frame-shift mutations and one nonsense mutation abolished the QT domain, containing a PCNA-binding domain and a nuclear localization signal. Two missense mutations occurred in the CDK inhibitory domain, diminishing its inhibitory function. The above-mentioned mutations were predicted by in silico analysis to lead to loss of function; therefore, we strongly suspect that such anomalies are causative in the etiology of BWS.
KEYWORD
Beckwith-Wiedemann syndrome, CDKN1C, Gene mutation, Genomic imprinting
FullTexts / Linksout information
Listed journal information
SCI(E) ÇмúÁøÈïÀç´Ü(KCI)